Johnson & Johnson announced a collaboration between the Janssen Pharmaceutical Companies of Johnson & Johnson and Emergent BioSolutions, Inc. to support the manufacturing of its lead investigational COVID-19 vaccine candidate. This is the first in a series of prospective global collaboration agreements designed to accelerate manufacturing of Johnson & Johnson’s COVID-19 vaccine candidate, and further the Company’s goal to supply more than one billion doses of the vaccine globally.
source https://www.pharmatutor.org/pharma-news/2020/johnson-and-johnson-collaborate-to-expand-manufacturing-capabilities-for-its-covid-19-vaccine
No comments:
Post a Comment